Ethiopian visceral leishmaniasis: Generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 6, 2001, Pages 668-672

  Ritmeijer, K ^a,b   Veeken, H ^a   Melaku, Y ^a   Leal, G ^a   Amsalu, R ^a   Seaman, J ^a   Davidson, R N ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Frontiéres Holland   (Netherlands)

Author keywords

Chemotherapy; Concurrent infections; Efficacy; Ethiopia; HIV infections; Pentostam; Sodium stibogluconate; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; ANTIMONY; GENERIC DRUG; STIBOGLUCONATE SODIUM;

ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE CARRIER; DISEASE SEVERITY; ETHIOPIA; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PNEUMONIA; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REMISSION; SKIN LEISHMANIASIS; SUPERINFECTION; VISCERAL LEISHMANIASIS; VOMITING;

HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIA DONOVANI; NASO HEXACANTHUS; PROTOZOA;

EID: 0035726313     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90110-5     Document Type: Article

References (11)

1. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients
2. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: A study of 37 strains collected from patients with visceral leishmaniasis
3. Treatment of visceral leishmaniasis in HIV-infected patients: A randomized trial comparing meglumine antimoniate with amphotericin B
4. Infection of sand flies by humans co-infected with Leishmania infantum and human immunodeficiency virus
5. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya
6. Epidemic visceral leishmaniasis in Sudan: A randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone
7. Epidemic visceral leishmaniasis in southern Sudan: Treatment of severely debilitated patients under wartime conditions and with limited resources
8. A randomised comparison of branded sodium stibogluconate (Pentostam, Glaxo Wellcome, London) and generic sodium stibogluconate (Albert David Ltd., Calcutta) for the treatment of visceral leishmaniasis under field conditions in Sudan
9. Leishmania/HIV co-infection, south-western Europe, 1990-1998. A retrospective analysis of 965 cases